Physicians' Academy for Cardiovascular Education

Burden of residual risk: Are triglycerides a risk marker?

10' education - Aug. 18, 2020 - Prof. Klaus Parhofer, MD - University Hospital Munich, Germany

Video navigation menu

  • Residual risk - hyperlipoproteinemia 02:25
  • Hypertriglyceridemia and atherosclerotic events 04:20
  • Hypertriglyceridemia and aortic valve stenosis 08:10
  • Important approximates of lipid-associated CV risk 10:09
  • Lipid goals in combined hyperlipoproteinemia 13:16

Do you think that triglycerides play a causal role in CVD?

  • Yes
  • No

Educational information

This lecture by prof. Klaus Parhofer, MD is part of the virtual symposium "Reducing Residual Risk for Cardiovascular Disease: Is there a role for non-LDL lowering agents?" from the German Cardiac Society.


Prof. Klaus Parhofer, MD – medical Clinic IV Groβhadern, University Hospital Munich, Germany


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.


Funding for this educational program was provided by an unrestricted educational grant from Amarin.

Share this page with your colleagues and friends: